Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
6th Dec 20245:00 pmRNSNet Asset Value(s)
3rd Dec 20244:40 pmRNSTransaction in Own Shares
3rd Dec 202410:05 amRNSNet Asset Value(s)
2nd Dec 202411:20 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSConclusion of Strategic Review & Change of Manager
25th Nov 202410:58 amRNSNet Asset Value(s)
18th Nov 202412:07 pmRNSTransaction in Own Shares
15th Nov 20244:14 pmRNSNet Asset Value(s)
8th Nov 20244:12 pmRNSNet Asset Value(s)
1st Nov 20244:28 pmRNSNet Asset Value(s)
1st Nov 20243:15 pmRNSTotal Voting Rights
30th Oct 20243:34 pmRNSTransaction in Own Shares
29th Oct 20241:26 pmRNSTransaction in Own Shares
28th Oct 20249:36 amRNSNet Asset Value(s)
22nd Oct 20242:05 pmRNSTransaction in Own Shares
21st Oct 20249:50 amRNSNet Asset Value(s)
14th Oct 20243:33 pmRNSTransaction in Own Shares
11th Oct 20244:40 pmRNSNet Asset Value(s)
8th Oct 20244:22 pmRNSTransaction in Own Shares
7th Oct 20241:16 pmRNSNet Asset Value(s)
2nd Oct 202410:36 amRNSNet Asset Value(s)
1st Oct 202410:00 amRNSTotal Voting Rights
27th Sep 20247:00 amRNSHalf-year Report
25th Sep 20243:12 pmRNSTransaction in Own Shares
23rd Sep 202410:28 amRNSNet Asset Value(s)
19th Sep 20249:12 amRNSDividend Declaration
13th Sep 20245:12 pmRNSNet Asset Value(s)
11th Sep 202411:05 amRNSTransaction in Own Shares
6th Sep 20244:57 pmRNSNet Asset Value(s)
4th Sep 20244:35 pmRNSTransaction in Own Shares
3rd Sep 20242:55 pmRNSNet Asset Value(s)
3rd Sep 20247:00 amRNSUpdate on Strategic Review
2nd Sep 202411:13 amRNSCompliance with Market Abuse Regulation
2nd Sep 202411:01 amRNSTotal Voting Rights
23rd Aug 20245:42 pmRNSNet Asset Value(s)
16th Aug 20244:39 pmRNSNet Asset Value(s)
12th Aug 20244:50 pmRNSTransaction in Own Shares
9th Aug 20245:18 pmRNSNet Asset Value(s)
5th Aug 20241:40 pmRNSTransaction in Own Shares
2nd Aug 202410:05 amRNSNet Asset Value(s)
1st Aug 20244:37 pmRNSTransaction in Own Shares
1st Aug 202411:40 amRNSTotal Voting Rights
26th Jul 20243:40 pmRNSNet Asset Value(s)
24th Jul 20242:31 pmRNSTransaction in Own Shares
23rd Jul 20242:45 pmRNSTransaction in Own Shares
22nd Jul 202410:31 amRNSNet Asset Value(s)
15th Jul 20245:16 pmRNSNet Asset Value(s)
8th Jul 202410:40 amRNSNet Asset Value(s)
2nd Jul 202412:02 pmRNSNet Asset Value(s)
1st Jul 20243:50 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.